Some of the topics discussed were:
1. Biosimilar Insulins:The RMOC is investigating the potential for increasing uptake of biosimilar insulins.
2. The RMOC Guidance on Prescribing of liothyronine was updated and published on the SPS website
3. Botulinium Toxin - It was agreed that an interim statement detailing current progress will be prepared and shared with the three other RMOCs.